leonero.blogg.se

1. #FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM CLASS II B SKIN#
2. #FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM CLASS II B PLUS#

Whenever a new CGM device becomes available, it is essential to critically evaluate its accuracy and usability.

In principle, the glucose sensing technique is based on the technique of the FreeStyle Navigator, which has been shown to be a reliable CGM measurement technique. The reader used for FSL-CGM also supports glucose and ketone capillary blood measurements using FreeStyle Precision glucose/ketone strips.

#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM CLASS II B PLUS#

Scanning of the sensor by a separate reader collects the glucose measurements and trend at the moment of scanning plus up to 8 hours of prior readings every 15 min. The sensor is put in place by a single-use applicator, and automatically measures glucose every minute for up to 14 days.

#FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM CLASS II B SKIN#

This flash glucose monitoring system measures interstitial glucose via disposable electronics and a subcutaneous sensor, with a button-like structure firmly adhering to the skin to allow the inserted sensor to stay in place. Recently, a different variety of continuous glucose monitoring (CGM FreeStyle Libre Flash (FSL-CGM), Abbot Diabetes Care, Alameda, California, USA) for interstitial glucose fluid monitoring has been introduced in Europe that is compact, lightweight, has a 2-week period of use, and according to the producer does not require calibration by the user (factory-calibrated). Nevertheless, with the advances in the development of highly accurate and easy to use CGM systems, the ultimate use of ‘artificial pancreas’ moves closer to become a reality. While improved glycemic control has been demonstrated with the use of CGM systems, 3–5 CGM accuracy also remains a challenge most of the available systems need calibrating at least twice daily to allow a sufficiently reliable correlation between interstitial and capillary glucose results. 2 These CGM systems measure interstitial fluid glucose levels at rather closely spaced intervals to provide semicontinuous information on glucose levels, allowing identification and signaling of glucose level fluctuations to a degree that cannot be obtained with intermittent capillary blood glucose measurements. In the past 15 years, continuous glucose monitoring (CGM) systems have become available. International standards have agreed on several criteria with regards to accuracy: an accuracy of ☑5% for glucose levels ≥100 mg/dL and ☑5 mg/dL for glucose levels <100 mg/dL of the actual blood glucose level are the most relevant criteria from a patient point of view, 1 since hypoglycemias do have the most immediate impact on patient's well-being and the degree of hypoglycemia does influence the measures needed to counteract the hypoglycemia. Also, intermittent blood glucose monitoring through intermittent capillary blood sampling provides only snapshots of glucose concentrations.Īnother important point of attention is the accuracy of the strips used to measure capillary blood glucose concentrations. However, many patients experience barriers to frequent testing, among others including the pain and discomfort associated with the finger-stick blood samples along with accumulated trauma to the fingers. Self-monitoring of blood glucose levels requires intermittent capillary blood sampling and a blood glucose measurement device.